ADA Scientific Sessions 2025 Abstract
Sodium–Glucose Cotransporter 2 Inhibitor Combined with Low-Carbohydrate Diets Safely Achieves Moderate Ketosis in Healthy Volunteers—An Open-Label Pilot Study
Trial in peopleInterventions
The paper
Orlando
ADA Scientific Sessions 2025 Abstract, 13 Jun 2025
Presented at ADA Scientific Sessions 2025, poster 913-P

